Literature DB >> 17149546

Inhibition of adenovirus-mediated human MAGE-D1 on angiogenesis in vitro and in vivo.

Wei-Gan Shen1, Qing-Yu Xue, Jun Zhu, Ben-Shun Hu, Yu Zhang, Yi-Ding Wu, Qing Su.   

Abstract

MAGE-D1 is a member of the MAGE family of proteins, and functions as an adaptor that mediates multiple signaling pathways. The current study for the first time provides evidence for a role of MAGE-D1 in the negative regulation of angiogenic activity in vitro and in vivo models. Our findings showed that MAGE-D1 over-expression significantly suppressed the angiogenic key events such as endothelial cell migration and invasion, adhesion on collagen I substrate, and in vitro differentiation into tube-like structures under both normoxic and hypoxic conditions. MAGE-D1 over-expression also inhibited in vivo angiogenesis in Matrigel plugs that were implanted subcutaneously in mice. With further experiments, we revealed that MAGE-D1 over-expression disrupted actin cytoskeleton organization and lamellipodia formation, and down-regulated HIF-1-dependent gene expression in endothelial cells under hypoxic conditions. These findings demonstrate a new function of MAGE-D1 in the regulation of angiogenesis and provide new insight into the ability of MAGE-D1 to suppress the growth and angiogenic response of endothelial cells by interfering with HIF-1-dependent gene expression, and actin cytoskeleton reorganization, suggesting that MAGE-D1 might be a novel inhibitor of angiogenesis in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149546     DOI: 10.1007/s11010-006-9373-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  44 in total

1.  UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE.

Authors:  Megan E Williams; Phyllis Strickland; Ken Watanabe; Lindsay Hinck
Journal:  J Biol Chem       Date:  2003-02-21       Impact factor: 5.157

Review 2.  Angiogenesis assays: a critical overview.

Authors:  Robert Auerbach; Rachel Lewis; Brenda Shinners; Louis Kubai; Nasim Akhtar
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 4.  Rho GTPases and the actin cytoskeleton.

Authors:  A Hall
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

Review 5.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 6.  RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins.

Authors:  Aya Sasaki; Lindsay Hinck; Ken Watanabe
Journal:  J Recept Signal Transduct Res       Date:  2005       Impact factor: 2.092

7.  NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.

Authors:  A H Salehi; P P Roux; C J Kubu; C Zeindler; A Bhakar; L L Tannis; J M Verdi; P A Barker
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

8.  A novel messenger ribonucleic acid homologous to human MAGE-D is strongly expressed in rat Sertoli cells and weakly in Leydig cells and is regulated by follitropin, lutropin, and prolactin.

Authors:  B Hennuy; E Reiter; A Cornet; M Bruyninx; M Daukandt; P Houssa; V H N'Guyen; J Closset; G Hennen
Journal:  Endocrinology       Date:  2000-10       Impact factor: 4.736

9.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Authors:  Selma Pennacchietti; Paolo Michieli; Maria Galluzzo; Massimiliano Mazzone; Silvia Giordano; Paolo M Comoglio
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

Review 10.  Rho GTPases and cell migration.

Authors:  A J Ridley
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  5 in total

1.  miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.

Authors:  Youngmi Kim; Deokbum Park; Hyuna Kim; Munseon Choi; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

2.  Maged1, a new regulator of skeletal myogenic differentiation and muscle regeneration.

Authors:  Tuan H N Nguyen; Mathieu J M Bertrand; Christiane Sterpin; Younes Achouri; Olivier R Y De Backer
Journal:  BMC Cell Biol       Date:  2010-07-20       Impact factor: 4.241

Review 3.  Complex roles of NRAGE on tumor.

Authors:  Ge Zhang; Huandi Zhou; Xiaoying Xue
Journal:  Tumour Biol       Date:  2016-05-21

4.  Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87.

Authors:  Xin-Li Liu; Dan Zhao; Da-Peng Sun; Yang Wang; Yan Li; Feng-Qi Qiu; Ping Ma
Journal:  J Exp Clin Cancer Res       Date:  2012-02-01

5.  NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Huandi Zhou; Guohui Wang; Zhiqing Xiao; Yu Yang; Zhesen Tian; Chen Gao; Xuetao Han; Wei Sun; Liubing Hou; Junling Liu; Xiaoying Xue
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.